Farmaci urologici autorizzati in Italia e i disturbi per cui si prendono, con revisione medica firmata

The Urologist

Email notifications

The mailing list that used to sit at this address is closed. No address is collected here, no message is sent from here, and there is no form left to fill in.

What the list carried

One line of text and one field, to receive immediate notifications of important new content added to the journal. In practice it announced a new issue and, twice, an editorial announcement: eleven messages between March 2012 and August 2015, all of them still listed in order on the notifications page.

Why there is nothing to subscribe to

The archive is complete. Eight issues appeared between 2012 and 2015, the last one in August 2015, and nothing further will be added to it. A subscription to the journal would now deliver silence.

Where the site does still change

Two sections are maintained rather than frozen. The farmacopea follows the summaries of product characteristics filed with AIFA, so a dosage, an interaction or a price changes there when the source does. The condition pages follow the guidelines of the European Association of Urology and move with them. How both are written, and against which sources they are checked, is set out in come sono scritte le schede.

How to see what changed, without email

  • The XML sitemap carries the date each page was last modified. Sorting it by that date is the quickest way to see what moved.
  • The site map is the readable version of the same list, by section.
  • Each drug sheet and each condition page carries the date of its last revision in the note beside the text.

If mail still arrives in the journal's name

It does not come from here. The unsubscribe page explains what separates such a message from the journal that actually published on this domain.